Premium Information is available for this item - Upgrade for $1 a day
5895-01-471-0445
Amplifier-Limiter
5895014710445 014710445 069662-1
A single component with the dual function of amplification and of electronically establishing parameters defining the maximum excursion of a signal(s). View more Amplifier-Limiter
January 2023
3

Marketplace 5895-01-471-0445
Request a Quotation from participating marketplace vendors
Related Documents 5895-01-471-0445 1+ Documents (More...)
/fsc-5895/us 5895-01-471-0445 Amplifier-Limiter 5895014710445014710445 United States (US) 4. 5895-01-
Amplifier-Limiter 5895014710445014710445 069662-1 A single component with Restrictions 5895-01-471-0445
Restrictions 5895-01-471-0445
5895-01-471-0445 is a Amplifier-Limiter that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is a US Munitions List or Commerce Control List Item which must be destroyed to prevent restoration or repair. Only authorized parties may possess this item. This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 5895-01-471-0445
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 5895-01-471-0445
- Turkey (ZW01)
- Effective Date:
- 1 Jan 2000
Approved Sources 5895-01-471-0445
- Part Number
- Manufacturer
- Status
- 069662-1
- Manufacturer
- 34228 - L3 Technologies, Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 5895-01-471-0445
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- End Item Identification [AGAV]
- Search Periscope Assy P/N 069504 No Nsn Assign;Search Periscope Assy P/N 073004 No Nsn Assign
Similar Supply Items to 5895-01-471-0445


















Freight Information 5895-01-471-0445
5895-01-471-0445 has freight characteristics managed by Turkey.. 5895-01-471-0445 has a variance between NMFC and UFC when transported by rail and the description should be consulted.